What is the share price of Encube Ethicals Ltd?

Company share prices are keep on changing according to the market conditions. The current trading price of Encube Ethicals Ltd on 01-Jan-1970 05:30:00 at 05:30 is .

What is the P/E ratio of Encube Ethicals?

The latest standalone P/E ratio of Encube Ethicals as of 01-Jan-1970 is 0.00.

What is the P/B ratio of Encube Ethicals Ltd?

The latest standalone P/B ratio of Encube Ethicals Ltd as of 01-Jan-1970 is 0.00.

What is the 52-week high and low of Encube Ethicals Ltd?

The 52-week high of Encube Ethicals Ltd is Rs. and the 52-week low is Rs. .

Encube Ethicals Ltd

Name: Encube Ethicals Ltd
Brand: Encube Ethicals

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Encube Ethicals Share Price

BSE Share Price
Not Listed

Encube Ethicals Ltd

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 0 NSE: Pharmaceuticals & Drugs | Small Cap | Encube Ethicals Share Price

BSE Share Price
Not Listed

Key Metrics

Valuation Multiples

Market Cap

₹0 Cr.

Current Price

₹0

52-Week Low / High

₹0 / 0

TTM EPS

₹0

TTM Sales

₹349 Cr.

Book Value per Share

P/E Ratio

0.00

Industry PE

53.4

Price to Book (P/B)

0.00

Price to Sales (P/S)

0.00

EV/EBITDA

0.00

Dividend Yield

NAN%

Profitability Efficiency

Return on Equity (ROE)

19.21%

Return on Capital Employed (ROCE)

24.75%

Return on Assets (ROA)

14.45%

Operating Profit Margin

35.6%

Net Profit Margin

22.11%

Gross Profit Margin

36.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

26.49%

Operating Profit Growth (1 Year)

Improving versus 3-year growth rate

38.34%

Net Profit Growth (1 Year)

Improving versus 3-year growth rate

44.49%

Asset Quality

Promoter Holding

Pledged shares (%) of Promoter's holding (%)

Reserves

₹478 Cr.

Equity

₹0 Cr.

Face Value

All Time Low / High

- / -

10 Year X-Ray :

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	47%	26%	-0.5%	-8.6%	5.1%	25.9%	20.2%	22.3%	20.7%	24.8%	-
Growth Parameters ⓘ
Sales ⓘ	293	311	301	349	390	543	643	937	1,037	1,312	349
Sales YoY Gr.	-	6.1%	-3.2%	16.3%	11.5%	39.5%	18.3%	45.8%	10.6%	26.5%	-
Adj EPS ⓘ	3.8	3.5	0.4	-2.6	0.9	6.5	4.7	8	9.8	14	0
YoY Gr.	-	-8.2%	-88.5%	-737.5%	NA	609.8%	-28.3%	70.7%	22.2%	43.4%	-
BVPS (₹) ⓘ	13.5	27.1	27.6	25.2	26.3	32.9	48.6	57.4	67.5	82	0
Adj Net Profit ⓘ	68.1	67.3	7.7	-49.4	17.9	126	94.8	162	198	284	NAN
Cash Flow from Ops. ⓘ	85.6	61.1	1.8	-19.8	26	135	48.3	92.6	191	291	-
Debt/CF from Ops. ⓘ	0	0	0	0	0	0	0	0.2	0.4	0.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	18.1%	27.5%	26.8%	26.5%
Adj EPS ⓘ	15.6%	72.4%	44.1%	43.4%
BVPSⓘ	22.2%	25.5%	19.1%	21.4%
Share Price	-	-	-	-

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	32.5	17.6	1.5	-9.7	3.6	22	11.7	15	15.5	18.7	0
Op. Profit Mgn % ⓘ	39.5	33.9	1	-7.9	12.9	33.1	28.6	30.3	32.3	35.6	NAN
Net Profit Mgn % ⓘ	23.3	21.7	2.6	-14.1	4.6	23.3	14.8	17.3	19.1	21.6	NAN
Debt to Equity ⓘ	0	0	0	0	0	0	0	0	0.1	0	-
Working Cap Days ⓘ	110	108	153	155	156	146	209	228	256	251	0
Cash Conv. Cycle ⓘ	52	55	88	83	74	57	77	89	120	109	0

Valuation of Encube Ethicals - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Management X-Ray

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Financials

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	292.76	310.61	300.57	349.42	389.51	543.30	642.90	937.20	1,036.90	1,311.60
Operating Expenses ⓘ +	177.13	205.69	297.48	377.17	339.43	363.80	458.80	653.70	702	848.30
Manufacturing Costs	22.21	32.16	131.11	184.31	127.27	105.90	54.10	60.90	113.80	110.10
Material Costs	109.58	119.42	118.29	134.21	140.75	168.30	230.50	353	356.10	434.80
Employee Cost	21.33	22.75	25.81	32.81	37.65	45.10	66.60	84.50	99.40	124.80
Other Costs ⓘ	24	31.36	22.28	25.83	33.76	44.50	107.60	155.30	132.70	178.60
Operating Profit ⓘ	115.63	104.91	3.08	-27.75	50.08	179.50	184.10	283.50	334.90	463.30
Operating Profit Margin (%)	39.5%	33.8%	1.0%	-7.9%	12.9%	33.0%	28.6%	30.2%	32.3%	35.3%
Other Income ⓘ +	8.02	19.95	22.91	16.63	17.64	12.60	24.70	24.80	11.90	22.20
Exceptional Items ⓘ	0	0	0	0	0	0	0	-2.10	-1.20	0
Interest ⓘ	0.25	0.15	0.22	0.24	1.69	2.40	4.10	4.70	4.80	8.60
Depreciation ⓘ	23.42	25.31	28.56	32.92	42.47	43.50	44.40	64.20	73.80	95.60
Profit Before Tax ⓘ	99.99	99.40	-2.79	-44.28	23.57	146.20	160.30	237.30	267	381.30
Tax ⓘ	31.85	29.49	-14.68	2.13	0.10	17.30	50.90	58.10	66.30	91.30
Profit After Tax	68.14	69.91	11.89	-46.40	23.47	128.90	109.40	179.20	200.70	290
PAT Margin (%)	23.3%	22.5%	4.0%	-13.3%	6.0%	23.7%	17.0%	19.1%	19.4%	22.1%
Adjusted EPS (₹)	3.8	3.6	0.6	-2.4	1.2	6.7	5.4	8.9	9.9	14.4
Dividend Payout Ratio (%)	2%	0.70%	4.10%	0%	0%	0%	0%	0%	0%	0%

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	243.12	523.61	534.32	487.57	509.53	637.28	984.03	1,163.30	1,363.80	1,655.50
Share Capital ⓘ	9	9.68	9.68	9.68	9.68	9.68	10.13	10.13	10.10	10.10
Reserves ⓘ	234.12	513.93	524.64	477.89	499.85	627.60	973.90	1,153.17	1,353.70	1,645.40
Debt +	0.15	0	0	0	0	0	0	15.90	50.90	21.80
Long Term Debt	0	0	0	0	0	0	0	14.60	41.30	21.80
Short Term Debt	0.15	0	0	0	0	0	0	1.30	9.60	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	20.43	16.87	45.04	40.56	47.86	64.70	112.70	129.50	151.80	229.20
Others Liabilities ⓘ	37.15	41.06	31.96	47.59	53.58	57.82	132.17	173.10	228.30	312.30
Total Liabilities ⓘ	300.85	581.53	611.32	575.71	610.98	759.80	1,228.90	1,481.80	1,794.80	2,218.80
Fixed Assets
Net Fixed Assets ⓘ +	139.29	163.70	172.79	213.68	235.77	220.50	380.60	472.80	741.90	867.10
Gross Block	209.74	188.92	226.37	299.44	363.95	385.30	584.60	726.10	1,074.10	1,271.20
Accumulated Depreciation	70.45	25.22	53.58	85.76	128.17	164.80	204	253.30	332.20	404.10
CWIP ⓘ	3.35	12.73	22.33	14.21	2.68	4.50	32.30	162.20	150.60	82
Investments ⓘ	59.45	300.40	256.93	184.73	167.05	261.30	309.40	103	94.40	220.10
Inventories	49.37	35.78	56.40	44.65	49.30	80.80	130.90	169	209.70	326.20
Trade Receivables	27.76	54.25	60.94	72.72	83.37	111.70	201.70	330.80	378.60	439.80
Cash Equivalents	0.58	0.85	7.93	18.44	17.46	28.20	15.40	63.40	33	23.70
Others Assets ⓘ	21.04	13.81	34	27.28	55.35	52.80	158.60	180.60	186.60	259.90
Total Assets ⓘ	300.85	581.53	611.32	575.71	610.98	759.80	1,228.90	1,481.80	1,794.80	2,218.80

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	85.56	61.11	1.80	-19.79	25.95	134.50	48.30	92.60	190.90	290.70
PBT ⓘ	99.99	99.40	-2.79	-44.28	23.39	146.20	160.30	237.30	267	381.30
Adjustment ⓘ	22.13	10.28	10.75	20.01	33.81	38.10	30.90	58.80	74.50	95.10
Changes in Working Capital ⓘ	-7.77	-16.04	-4.65	6.38	-29.7	-28.4	-118.1	-154	-97	-111.9
Tax Paid ⓘ	-29.50	0	-1.52	-1.90	-1.55	-21.50	-24.80	-49.50	-53.60	-73.80
Cash Flow From Investing Activity ⓘ +	-76.53	-271.13	5.86	30.30	-22.65	-117.70	-288	-54.20	-253.60	-271.30
Capex	0.06	-45.65	-55.14	-54.20	-49.41	-28.80	-251.40	-271.40	-278.70	-148.10
Net Investments	0	-225.75	60.98	84.46	27.81	-86.50	-31.80	216.20	24.50	-124
Others ⓘ	-76.60	0.26	0.02	0.04	-1.05	-2.40	-4.80	1	0.60	0.80
Cash Flow From Financing Activity ⓘ +	-9.03	210.29	-0.58	-0	-4.29	-5.60	227	9.60	33.50	-28.60
Net Proceeds from Shares ⓘ	0	210.93	0	0	0	0	248	0	0	0.40
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	15	43.70	-17.60
Interest Paid ⓘ	0	-0	-0	-0	0	-0.90	-0.60	-2.80	-4.30	-5.40
Dividend Paid ⓘ	0	0	-0.58	0	0	0	0	0	0	0
Others ⓘ	-9.03	-0.63	0	0	-4.29	-4.70	-20.40	-2.60	-5.90	-6
Net Cash Flow ⓘ	-0	0.27	7.08	10.51	-0.98	11.20	-12.70	48	-29.20	-9.20

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	32.47	18.24	2.25	-9.08	4.71	22.48	13.5	16.69	15.88	19.21
ROCE (%)	47.04	25.96	-0.49	-8.62	5.07	25.87	20.2	22.25	20.68	24.75
Asset Turnover Ratio	1.15	0.77	0.51	0.59	0.66	0.79	0.65	0.69	0.63	0.65
PAT to CFO Conversion(x)	1.26	0.87	0.15	N/A	1.11	1.04	0.44	0.52	0.95	1
Working Capital Days
Receivable Days	33.10	43.80	69.10	69.80	73.10	65.50	89	103.70	124.90	113.90
Inventory Days	47	45.50	55.30	52.80	44	43.70	60.10	58.40	66.70	74.60
Payable Days	48.20	57	95.50	116.40	114.70	122.10	140.50	125.20	144.20	159.90

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Encube Ethicals Ltd FAQs

The current trading price of Encube Ethicals on 01-Jan-1970 05:30 is ₹0.00.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 31-Dec-1969 the market cap of Encube Ethicals stood at ₹0.00 Cr

The latest P/E ratio of Encube Ethicals as of 31-Dec-1969 is 0.00.

The latest P/B ratio of Encube Ethicals as of 31-Dec-1969 is 0.00.

The 52-week high of Encube Ethicals is ₹0.00 and the 52-week low is ₹0.00.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Encube Ethicals is ₹349 ( Cr.) .

Data is not available for this company.

No data found

About Encube Ethicals Ltd

No data to display

You have 4 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045

Compliance Officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com	Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com	Telephone: +919860919463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com	Telephone: +919175899463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Encube Ethicals Ltd

Encube Ethicals Ltd

10 Year X-Ray :